May 06, 2020 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Vanda Pharmaceuticals Inc. Earnings Conference Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. Kevin Moran, Vanda's acting Chief Financial Officer. Thank you, sir. You may begin.
Kevin Patrick Moran - Vanda Pharmaceuticals Inc. - Acting CFO, VP & Treasurer
Thanks, Oren. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' first quarter 2020 performance. Our first quarter 2020 results released this afternoon and are available on the SEC's EDGAR system and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.
Joining me on today's call is Dr. Mihael Polymeropoulos, our President and CEO. Following my introductory remarks, Mihael will update you on our ongoing activities. I will then comment on our financial results before opening the lines for
Q1 2020 Vanda Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot